• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

达芬奇机器人单吻合十二指肠-回肠旁路术联合袖状胃切除术治疗肥胖患者的安全性及学习曲线

[Safety and learning curve of Da Vinci robotic single-anastomosis duodenal-ileal bypass with sleeve gastrectomy in the treatment of obesity patients].

作者信息

Wang L, Zhao Y H, Wang Z Y, Yu Y, Wang J F, Jiang T

机构信息

Department of Bariatric and Metabolic Surgery, China-Japan Union Hospital, Jilin University, Changchun 130033, China.

出版信息

Zhonghua Wei Chang Wai Ke Za Zhi. 2022 May 25;25(5):454-461. doi: 10.3760/cma.j.cn441530-20210711-00273.

DOI:10.3760/cma.j.cn441530-20210711-00273
PMID:35599401
Abstract

To investigate the safety and learning curve of Da Vinci robotic single-anastomosis duodenal-ileal bypass with sleeve gastrectomy (SADI-S) in the treatment of obesity patients. A descriptive case series study was performed. Clinical data of obesity patients who were treated with Da Vinci robotic SADI-S in China-Japan Union Hospital of Jilin University from March 2020 to May 2021 were analyzed retrospectively. Case inclusion criteria: (1) uncomplicated obese patients with body mass index (BMI)≥37.5 kg/m(2); (2) patients with BMI of 28 to <37.5 kg/m(2) complicated with type 2 diabetes or two metabolic syndrome components, or obesity comorbidities; (3) patients undergoing SADI-S by Da Vinci robotic surgery system. Those who received other bariatric procedures other than SADI-S or underwent Da Vince robotic SADI-S as revisional operation were excluded. A total of 77 patients were enrolled in the study, including 31 males and 46 females, with median age of 33 (18-59) years, preoperative body weight of (123.0±26.2) kg, BMI of (42.2±7.1) kg/m(2) and waistline of (127.6±16.3) cm. According to the order of operation date, the patients were numbered as 1-77. The textbook outcome (TO) and Clavien-Dindo grading standard were used to analyze the clinical outcome of each patient and to classify surgical complications, respectively. The standard of textbook outcome was as follows: the operative time less than or equal to the 75th percentile of the patient's operation time (210 min); the postoperative hospital stay less than or equal to the 75th percentile of the patient's postoperative hospital stay (7 d); complication grade lower than Clavien grade II; no readmission; no conversion to laparotomy or death. The patient undergoing robotic SADI-S was considered to meet the TO standard when meeting the above 5 criteria. The TO rate was calculated by cumulative sum analysis (CUSUM) method. The curve was drawn by case number as X-axis and CUSUM (TO rate) as Y-axis so as to understand the learning curve of robotic SADI-S. The operative time of 77 robotic SADI-S was (182.9±37.5) minutes, and the length of postoperative hospital stay was 6 (4-55) days. There was no conversion to laparotomy or death. Seven patients suffered from complications (7/77, 9.1%). Four patients had grade II complications (5.2%), including one with duodeno-ileal anastomotic leakage, one with abdominal bleeding, one with peritoneal effusion and one with delayed gastric emptying; two patients were grade IIIb complications (2.6%) and both of them were diagnosed with gastric leakage; one patient was grade IV complication diagnosed with postoperative respiratory failure (1.3%), and all of them were cured successfully. A total of 51 patients met the textbook outcome standard, and the TO rate was positive and was steadily increasing after the number of surgical cases accumulated to the 46th case. Taking the 46th case as the boundary, all the patients were divided into learning stage group (=46) and mastery stage group (=31). There were no significant differences between the two groups in terms of gender, age, weight, body mass index, waist circumference, ASA classification, standard liver volume, operative time and morbidity of postoperative complication (all >0.05). The percent of abdominal drainage tube in learning stage group was higher than that in mastery stage group (54.3% versus 16.1%, <0.05). The length of postoperative hospital stay in learning stage group was longer than that in mastery stage group [6 (4-22) d versus 6 (5-55) d, <0.05)]. The Da Vinci robotic SADI-S is safe and feasible with a learning curve of 46 cases.

摘要

探讨达芬奇机器人单吻合口十二指肠-回肠转流术联合袖状胃切除术(SADI-S)治疗肥胖患者的安全性及学习曲线。进行了一项描述性病例系列研究。回顾性分析2020年3月至2021年5月在吉林大学中日联谊医院接受达芬奇机器人SADI-S治疗的肥胖患者的临床资料。病例纳入标准:(1)体重指数(BMI)≥37.5 kg/m²的单纯肥胖患者;(2)BMI为28至<37.5 kg/m²且合并2型糖尿病或两种代谢综合征成分,或肥胖合并症的患者;(3)通过达芬奇机器人手术系统接受SADI-S的患者。排除接受SADI-S以外的其他减肥手术或接受达芬奇机器人SADI-S作为翻修手术的患者。共纳入77例患者,其中男性31例,女性46例,中位年龄33(18 - 59)岁,术前体重(123.0±26.2)kg,BMI(42.2±7.1)kg/m²,腰围(127.6±16.3)cm。根据手术日期顺序,将患者编号为1 - 77。采用教科书式结局(TO)和Clavien-Dindo分级标准分别分析每位患者的临床结局并对手术并发症进行分类。教科书式结局标准如下:手术时间小于或等于患者手术时间的第75百分位数(210分钟);术后住院时间小于或等于患者术后住院时间的第75百分位数(7天);并发症等级低于Clavien II级;无再次入院;无中转开腹或死亡。接受机器人SADI-S的患者在满足上述5条标准时被认为达到TO标准。采用累积和分析(CUSUM)方法计算TO率。以病例数为X轴、CUSUM(TO率)为Y轴绘制曲线,以了解机器人SADI-S的学习曲线。77例机器人SADI-S的手术时间为(182.9±37.5)分钟,术后住院时间为6(4 - 55)天。无中转开腹或死亡。7例患者发生并发症(7/77,9.1%)。4例患者发生II级并发症(5.2%),包括1例十二指肠-回肠吻合口漏、1例腹腔出血、1例腹腔积液和1例胃排空延迟;2例患者发生IIIb级并发症(2.6%),均诊断为胃漏;1例患者发生IV级并发症,诊断为术后呼吸衰竭(1.3%),所有患者均成功治愈。共有51例患者达到教科书式结局标准,TO率为阳性,且在手术病例数累计至第46例后呈稳步上升趋势。以第46例为界,将所有患者分为学习阶段组(≤46例)和熟练阶段组(>46例)。两组在性别、年龄、体重、体重指数、腰围、ASA分级、标准肝体积、手术时间和术后并发症发生率方面均无显著差异(均>0.05)。学习阶段组腹腔引流管留置率高于熟练阶段组(54.3%对16.1%,<0.05)。学习阶段组术后住院时间长于熟练阶段组[6(4 - 22)天对6(5 - 55)天,<0.05]。达芬奇机器人SADI-S安全可行,学习曲线为46例。

相似文献

1
[Safety and learning curve of Da Vinci robotic single-anastomosis duodenal-ileal bypass with sleeve gastrectomy in the treatment of obesity patients].达芬奇机器人单吻合十二指肠-回肠旁路术联合袖状胃切除术治疗肥胖患者的安全性及学习曲线
Zhonghua Wei Chang Wai Ke Za Zhi. 2022 May 25;25(5):454-461. doi: 10.3760/cma.j.cn441530-20210711-00273.
2
Outcomes of totally robotic single-anastomosis duodenal-ileal bypass with sleeve gastrectomy: A large single-centre series.全机器人单吻合十二指肠-回肠旁路术联合袖状胃切除术的疗效:一项大型单中心研究系列
Asian J Surg. 2023 Jan;46(1):501-507. doi: 10.1016/j.asjsur.2022.06.009. Epub 2022 Jun 16.
3
Evaluation of the learning curve for robotic single-anastomosis duodenal-ileal bypass with sleeve gastrectomy.机器人辅助单吻合十二指肠-回肠旁路术联合袖状胃切除术学习曲线的评估
Front Surg. 2022 Jul 22;9:969418. doi: 10.3389/fsurg.2022.969418. eCollection 2022.
4
[One-year outcomes of laparoscopic single-anastomosis duodenal-ileal bypass with sleeve gastrectomy versus laparoscopic sleeve gastrectomy for the treatment of obesity and obesity-related metabolic diseases].腹腔镜单吻合十二指肠-回肠旁路术联合袖状胃切除术与腹腔镜袖状胃切除术治疗肥胖及肥胖相关代谢性疾病的一年结局
Zhonghua Wei Chang Wai Ke Za Zhi. 2021 Dec 25;24(12):1058-1064. doi: 10.3760/cma.j.cn441530-20210126-00044.
5
[Comprehensive evaluation of single-anastomosis duodenal-ileal bypass with sleeve gastrectomy in obese patients based on efficacy and nutrition].基于疗效和营养对肥胖患者行单吻合口十二指肠-回肠旁路术联合袖状胃切除术的综合评估
Zhonghua Wei Chang Wai Ke Za Zhi. 2024 Sep 25;27(9):945-952. doi: 10.3760/cma.j.cn441530-20230810-00041.
6
[Robot-assisted single-anastomosis duodeno-ileal bypass with sleeve gastrectomy].[机器人辅助单吻合十二指肠-回肠旁路术联合袖状胃切除术]
Zhonghua Wei Chang Wai Ke Za Zhi. 2021 May 25;24(5):449-451. doi: 10.3760/cma.j.cn.441530-20210111-00013.
7
[Analysis of the 1-year curative efficacy of sleeve gastrectomy, Roux-en-Y gastric bypass, single anastomosis duodenal-ileal bypass with sleeve gastrectomy and biliopancreatic diversion with duodenal switch in patients with super obesity].[袖状胃切除术、Roux-en-Y胃旁路术、袖状胃切除术联合单吻合十二指肠-回肠旁路术以及胆胰转流十二指肠转位术治疗超级肥胖患者的1年疗效分析]
Zhonghua Wei Chang Wai Ke Za Zhi. 2023 Sep 25;26(9):859-865. doi: 10.3760/cma.j.cn441530-20221025-00431.
8
Robotic vs laparoscopic approach for single anastomosis duodenal-ileal bypass with sleeve gastrectomy: a propensity score matching analysis.机器人与腹腔镜辅助单吻合口十二指肠空肠旁路术联合袖状胃切除术的比较:倾向评分匹配分析。
Updates Surg. 2023 Jan;75(1):175-187. doi: 10.1007/s13304-022-01381-8. Epub 2022 Sep 25.
9
[Mid-term efficacy of single anastomosis duodenal-ileal bypass with sleeve gastrectomy in the treatment of obesity and type 2 diabetes mellitus].单吻合十二指肠-回肠旁路术联合袖状胃切除术治疗肥胖症和2型糖尿病的中期疗效
Zhonghua Wei Chang Wai Ke Za Zhi. 2024 Oct 25;27(10):1056-1062. doi: 10.3760/cma.j.cn441530-20231007-00117.
10
Evaluation study of single-anastomosis duodenal-ileal bypass with sleeve gastrectomy in the treatment of Chinese obese patients based on efficacy and nutrition.基于疗效和营养评估的单吻合口十二指肠-空肠旁路袖状胃切除术治疗中国肥胖患者的研究
Sci Rep. 2024 Mar 19;14(1):6522. doi: 10.1038/s41598-024-57289-3.